Publicaciones (77) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. A documental approach to adventure game development

    Science of Computer Programming, Vol. 67, Núm. 1, pp. 3-31

  2. A highly modular and extensible architecture for an integrated IMS-based authoring system: The 〈e-Aula〉 experience

    Software - Practice and Experience, Vol. 37, Núm. 4, pp. 441-461

  3. Algunos datos nuevos sobre las relaciones Iglesia-Estado durante la Segunda República Española: documentación inédita del Nuncio Tedeschini en el Archivo Secreto Vaticano

    Ius canonicum, Vol. 47, Núm. 94, pp. 465-493

  4. Amino acid conservation in the gp41 transmembrane protein and natural polymorphisms associated with enfuvirtide resistance across HIV-1 variants

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 9, pp. 1067-1074

  5. Automatic cognitive style identification of digital library users for personalization

    Journal of the American Society for Information Science and Technology, Vol. 58, Núm. 2, pp. 237-251

  6. Automatic generation of cognitive theories using genetic programming

    Minds and Machines, Vol. 17, Núm. 3, pp. 287-309

  7. Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 45, Núm. 4, pp. 439-444

  8. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors

    Infection, Genetics and Evolution, Vol. 7, Núm. 3, pp. 382-390

  9. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 6, pp. 1141-1147

  10. Care of patients coinfected with HIV and hepatitis C virus: 2007 Updated recommendations from the HCV-HIV International Panel

    AIDS, Vol. 21, Núm. 9, pp. 1073-1089

  11. Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

    Journal of Infection, Vol. 54, Núm. 2, pp. 173-179

  12. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART

    AIDS, Vol. 21, Núm. 18, pp. 2521-2527

  13. Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 7, pp. 879-885

  14. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

    Journal of Viral Hepatitis, Vol. 14, Núm. 6, pp. 392-395

  15. Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients

    Antiviral Therapy, Vol. 12, Núm. 2, pp. 247-252

  16. Cohorte RIS de pacientes con infección por VIH sin tratamiento antirretroviral previo (CoRIS): Metodología y primeros resultados

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 1, pp. 23-31

  17. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

    AIDS, Vol. 21, Núm. 11, pp. 1487-1490

  18. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients

    Journal of Viral Hepatitis, Vol. 14, Núm. 6, pp. 387-391

  19. Drug interactions of tipranavir, a new HIV protease inhibitor.

    Drug metabolism letters, Vol. 1, Núm. 1, pp. 81-84

  20. Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV infection: The ELADI study

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 10, pp. 1237-1241